摘要
目的:建立羟丙基二淀粉磷酸酯(HPDSP)中基因杂质氯丙醇检测方法。方法:使用气相色谱-质谱联用仪(GC-MS),采用Agilent VF-WAX毛细管色谱柱,柱温为程序升温(起始温度为80℃,保持8 min,再以35℃·min^(-1)的速率升至220℃,保持5 min),流速2 mL·min^(-1),进样口温度200℃,不分流进样,进样量1μL。检测器为电子轰击源(EI)质谱检测器,离子源温度为230℃,检测模式为选择性离子监测(SIM),1-氯-2-丙醇定性离子的m/z为45、43、79、81,定量离子的m/z为79,2-氯-1-丙醇定性离子的m/z为58、62、63、64、65,定量离子的m/z为62。结果:1-氯-2-丙醇质量浓度在20.04~1 002 ng·mL^(-1)范围内线性关系良好(r=0.999 8,n=7);回收率为93.7%~117.1%;9批样品检测出氯丙醇含量范围为0.000 006%~0.000 08%。结论:该方法的检测灵敏度高,精密度好,准确度高,线性关系良好,可用于HPDSP中基因杂质氯丙醇的测定。
Objective:To establish a method for the detection of genetic impurity chloropropanol in hydroxypropyl distarch phosphate(HPDSP). Methods: The method was performed with Agilent VF-WAX capillary column and temperature programmed by GC-MS. The initial temperature was 80 ℃ for 8 min, then increased to 220 ℃ at the rate of 35 ℃·min^(-1) and maintained for 5 min with the flow rate of 2 mL·min^(-1). The temperature of inlet was 200 ℃, and the injection volume was 1 μL without split. The detector was electron impact(EI) with selected ion monitoring(SIM) mode and ion source temperature at 230 ℃. The m/z of qualitative ions of 1-chloro-2-propanol were 45, 43, 79, 81, and the m/z of quantitative ion was 79. The m/z of qualitative ions of 2-chloro-1-propanol were m/z 58, 62, 63, 64, 65, and m/z of the quantitative ion was 62. Results: Good linear was achieved in the range of 20.04 ng·mL^(-1) to 1 002 ng·mL^(-1 )(r=0.999 8,n=7) and the recovery rate ranged from 93.7% to 117.1% for 1-chloro-2-propanol. The contents of chloropropanol in 9 batches were within the range of 0.000 006%-0.000 08%. Conclusion: The method shows the advantages of high sensitivity, good accuracy, linearity and can be used for the detection of genetic impurities in HPDSP.
作者
叶秀金
胡淑君
陈英
王淼
李艺
王彩媚
YE Xiu-jin;HU Shu-jun;CHEN Ying;WANG Miao;LI Yi;WANG Cai-mei(Guangdong Institute for Drug Control,CFDA Key Laboratory of Quality Control and Evaluation of Pharmaceutical Excipients,Guangzhou 510663,China)
出处
《药物分析杂志》
CAS
CSCD
北大核心
2024年第1期109-115,共7页
Chinese Journal of Pharmaceutical Analysis
基金
广东省科技计划项目(2018B020207008)
广东省药品监督管理局科技创新项目(2021YDZ01)。